Pemetrexed sensitizes cisplatin therapy by inducing ferroptosis in NSCLC cells

In summary, these results provide <i>in vitro</i> experimental evidence that PEM boosts the antitumor activity and increases the sensitivity of NSCLC cells to DDP by inducing ferroptosis.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-21
DOI
https://doi.org/10.3389/fphar.2025.1764937
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pemetrexed sensitizes cisplatin therapy by inducing ferroptosis in NSCLC cells

J. Chen, Yuwei Cao, X. Zhang, Yumin Wang et al.
Frontiers in Pharmacology
Ferroptosis and cancer prognosis
article

Pemetrexed sensitizes cisplatin therapy by inducing ferroptosis in NSCLC cells

J. Chen, Yuwei Cao, X. Zhang, Yumin Wang, Y. Zhu, Yulin Li, Ge Zhang
article en

Abstract

In summary, these results provide <i>in vitro</i> experimental evidence that PEM boosts the antitumor activity and increases the sensitivity of NSCLC cells to DDP by inducing ferroptosis.

Frontiers in PharmacologyVol. 16
King University (US), Aerospace Center Hospital (CN)
Wu Jieping Medical Foundation
Good health and well-being
Openalex Percentile: Top 82%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.